Ohr Pharmaceuticals, Inc. (OHRP) Releases Quarterly Earnings Results, Misses Estimates By $0.02 EPS
Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP) released its quarterly earnings data on Tuesday. The company reported ($0.21) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.19) by $0.02.
Shares of Ohr Pharmaceuticals (NASDAQ:OHRP) traded down 9.52% on Thursday, hitting $0.95. The stock had a trading volume of 812,369 shares. The firm’s market capitalization is $34.16 million. Ohr Pharmaceuticals has a 12-month low of $0.95 and a 12-month high of $4.05. The company has a 50 day moving average of $1.45 and a 200-day moving average of $2.40.
“Ohr Pharmaceuticals, Inc. (OHRP) Releases Quarterly Earnings Results, Misses Estimates By $0.02 EPS” was originally posted by Watch List News and is the property of of Watch List News. If you are reading this report on another website, it was illegally stolen and reposted in violation of United States & international copyright legislation. The correct version of this report can be read at http://www.watchlistnews.com/ohr-pharmaceuticals-inc-ohrp-releases-quarterly-earnings-results-misses-estimates-by-0-02-eps/1120863.html.
A number of equities research analysts have weighed in on OHRP shares. Zacks Investment Research raised Ohr Pharmaceuticals from a “hold” rating to a “buy” rating and set a $1.75 price objective on the stock in a report on Friday, January 20th. HC Wainwright reaffirmed a “buy” rating and set a $10.00 price objective on shares of Ohr Pharmaceuticals in a report on Tuesday, December 13th. Three investment analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average price target of $13.69.
Receive News & Ratings for Ohr Pharmaceuticals Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ohr Pharmaceuticals Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.